Marotta P J, Graziadei I W, Ghent C N
London Health Sciences Centre, London, Canada.
Can J Gastroenterol. 2000 Nov;14 Suppl D:21D-25D. doi: 10.1155/2000/214916.
Muscle cramps are a common complaint in clinical practice. They are associated with various metabolic, endocrine, neurological and electrolyte abnormalities. A variety of hypotheses have been generated to explain the cause of muscle cramping, yet none has been able to support a consistent pathophysiological mechanism. Muscle cramps are painful, involuntary contractions of skeletal muscle. They occur frequently in individuals with cirrhosis, regardless of the etiology, and are thought to be a symptom of cirrhotic-stage liver disease. The pathophysiology of these cramps remains elusive; hence, a specific therapy has not been identified. Many therapeutic approaches have been offered, yet their efficacy, safety and mechanism of action remain poorly defined. This review defines muscle cramps and illuminates its prevalence in the cirrhotic individual. Current theories relating to the pathogenesis of muscle cramps are reviewed, and an overview of the various pharmacological agents that have had therapeutic success for this distressing and frustrating symptom is provided.
肌肉痉挛是临床实践中常见的主诉。它们与各种代谢、内分泌、神经和电解质异常有关。人们提出了各种假说来解释肌肉痉挛的原因,但没有一个能够支持一致的病理生理机制。肌肉痉挛是骨骼肌的疼痛性、非自主性收缩。它们在肝硬化患者中频繁发生,无论病因如何,被认为是肝硬化期肝病的一种症状。这些痉挛的病理生理学仍然难以捉摸;因此,尚未确定具体的治疗方法。已经提出了许多治疗方法,但其疗效、安全性和作用机制仍不明确。本综述对肌肉痉挛进行了定义,并阐明了其在肝硬化个体中的患病率。回顾了目前与肌肉痉挛发病机制相关的理论,并概述了对这种令人痛苦和沮丧的症状有治疗效果的各种药物。